Craft

Embera NeuroTherapeutics

Total Funding

$27.1 M

Embera NeuroTherapeutics Summary

Company Summary

Overview
Embera NeuroTherapeutics is a pharmaceutical company developing treatments for addiction. It offers a medication aimed at treating addiction by moderating activity in the stress response system. The company serves patients with cocaine and tobacco use disorders, as well as other substance abuse issues.
Type
Private
Status
Active
Founded
2005
Website
https://emberaneuro.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Robert B. Linke

    Robert B. Linke, Executive Chairman, Director

    • John B. Beaird, Director

      • Gary Connor

        Gary Connor, Vice President, Clinical Operations

        • Ross P. Barrett, Director

          Footer menu